(Q39788891)

English

Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma

scientific article published on 29 January 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 September 2017

Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma (English)

1 reference

Europe PubMed Central

14 September 2017

Pleomorphic xanthoastrocytoma

1 reference

based on heuristic

inferred from title

Martin Hasselblatt

10

1 reference

Europe PubMed Central

14 September 2017

Andreas von Deimling

17

object named as

Andreas von Deimling

0 references

Christel Herold-Mende

6

object named as

Christel Herold-Mende

0 references

Stefan M. Pfister

object named as

Stefan Pfister

13

0 references

object named as

David Capper

2

0 references

5

object named as

Heymut Omran

1 reference

Europe PubMed Central

14 September 2017

Guido Reifenberger

16

object named as

Guido Reifenberger

1 reference

Europe PubMed Central

14 September 2017

Andrey Korshunov

12

object named as

Andrey Korshunov

1 reference

Europe PubMed Central

14 September 2017

author name string

Genevieve Schindler

1

1 reference

Europe PubMed Central

14 September 2017

Jochen Meyer

3

1 reference

Europe PubMed Central

14 September 2017

Wibke Janzarik

4

1 reference

Europe PubMed Central

14 September 2017

Kirsten Schmieder

7

1 reference

Europe PubMed Central

14 September 2017

Pieter Wesseling

8

1 reference

Europe PubMed Central

14 September 2017

Christian Mawrin

9

1 reference

Europe PubMed Central

14 September 2017

David N Louis

11

1 reference

Europe PubMed Central

14 September 2017

Christian Hartmann

14

1 reference

Europe PubMed Central

14 September 2017

Werner Paulus

15

1 reference

Europe PubMed Central

14 September 2017

publication date

29 January 2011

1 reference

Europe PubMed Central

14 September 2017

Acta Neuropathologica

1 reference

Europe PubMed Central

14 September 2017

121

1 reference

Europe PubMed Central

14 September 2017

397-405

1 reference

Europe PubMed Central

14 September 2017

3

1 reference

Europe PubMed Central

14 September 2017

https://scigraph.springernature.com/pub.10.1007/s00401-011-0802-6

0 references

Atypical teratoid/rhabdoid tumor evolving from an optic pathway ganglioglioma: case study

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0802-6

21 January 2018

Mutation analysis of B-RAF gene in human gliomas.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0802-6

21 January 2018

Study of the MIB-1 labeling index as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0802-6

21 January 2018

Atypical teratoid/rhabdoid tumor arising in the setting of a pleomorphic xanthoastrocytoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0802-6

21 January 2018

Mutations of the BRAF gene in human cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0802-6

21 January 2018

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0802-6

21 January 2018

Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0802-6

21 January 2018

Temporal lobe tumor demonstrating ganglioglioma and pleomorphic xanthoastrocytoma components. Case report

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0802-6

21 January 2018

Antitumor efficacy of the novel RAF inhibitor GDC-0879 is predicted by BRAFV600E mutational status and sustained extracellular signal-regulated kinase/mitogen-activated protein kinase pathway suppression.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0802-6

21 January 2018

Association of molecular alterations, including BRAF, with biology and outcome in pilocytic astrocytomas

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0802-6

21 January 2018

Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0802-6

21 January 2018

RAS/RAF pathway activation in gliomas: the result of copy number gains rather than activating mutations.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0802-6

21 January 2018

Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0802-6

21 January 2018

Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0802-6

21 January 2018

Mutation analysis of the Ras pathway genes NRAS, HRAS, KRAS and BRAF in glioblastomas.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0802-6

21 January 2018

Pleomorphic xanthoastrocytoma with a gangliomatous component: an immunohistochemical and ultrastructural study

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0802-6

21 January 2018

Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0802-6

21 January 2018

Resequencing analysis of the human tyrosine kinase gene family in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0802-6

21 January 2018

Pleomorphic xanthoastrocytoma as a component of a cerebellar ganglioglioma: case report.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0802-6

21 January 2018

BRAF(E600) in benign and malignant human tumours

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0802-6

21 January 2018

BRAFE600-associated senescence-like cell cycle arrest of human naevi

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0802-6

21 January 2018

Targeting the RAF-MEK-ERK pathway in cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0802-6

21 January 2018

Composite pleomorphic xanthoastrocytoma and ganglioglioma: report of four cases and review of the literature

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0802-6

21 January 2018

BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0802-6

21 January 2018

Activated BRAF induces gliomas in mice when combined with Ink4a/Arf loss or Akt activation.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0802-6

21 January 2018

Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0802-6

21 January 2018

Pleomorphic xanthoastrocytoma as a component of a temporal lobe cystic ganglioglioma: a case report.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0802-6

21 January 2018

Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0802-6

21 January 2018

Pleomorphic xanthoastrocytoma with gangliogliomatous component.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0802-6

21 January 2018

Frequent loss of chromosome 9, homozygous CDKN2A/p14(ARF)/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0802-6

21 January 2018

RG7204 (PLX4032), a selective BRAFV600E inhibitor, displays potent antitumor activity in preclinical melanoma models

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0802-6

21 January 2018

Alterations of BRAF and HIPK2 loci predominate in sporadic pilocytic astrocytoma

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0802-6

21 January 2018

Identifiers

10.1007/S00401-011-0802-6

1 reference

Europe PubMed Central

14 September 2017

1 reference

Europe PubMed Central

14 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39788891&oldid=2090404467"